Kinsner-OvaskainenA., BulgheroniA., HartungT. & PrietoP. (2009). ECVAM's ongoing activities in the area of acute oral toxicity. Toxicology in Vitro23, 1535–1540. [Special Issue: Proceedings of the ESTIV 2008 Congress.]
2.
FortiE., BulgheroniA., CetinY., HartungT., JenningsP., PfallerW. & Prieto PeraitaM. (2010). Characterisation of cadmium chloride induced molecular and functional alterations in bronchial epithelial cells. Cellular Physiology & Biochemistry25, 159–168.
3.
HogbergH., Kinsner-OvaskainenA., CoeckeS., HartungT. & PriceA. (2010). mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicological Sciences113, 95–115.
4.
ScottL., EskesC., HoffmannS., AdriaensE., AlepéeN., BufoM., ClothierR., FacchiniD., FallerC., GuestR., HarbellJ., HartungT., KampH., VarletB.L., MeloniM., McNameeP., OsborneR., PapeW., PfannenbeckerU., PrinsenM., SeamanC., SpielmannH., StokesW., TroubaK., BergheC.V., GoethemF.V., VassalloM., VinardellP. & ZuangV. (2010). A proposed eye irritation testing strategy to reduce and replace in vivo studies using Bottom-Up and Top-Down approaches. Toxicology in Vitro24, 1–9.
5.
PriceA., HogbergH., BuzanskaL. & CoeckeS. (2010). Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicology & Teratology32, 36–41.